{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:31:03Z","timestamp":1788957063003,"version":"build-2803163510"},"reference-count":11,"publisher":"Jaypee Brothers Medical Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.59556\/japi.74.1427","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:12:57Z","timestamp":1773378777000},"page":"56-58","source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathological Spectrum and Biomarker Profile of Male Breast Cancer: A Retrospective Study from a Tertiary Care Center in South India"],"prefix":"10.59556","volume":"74","author":[{"given":"Sanjana Reddy","family":"Potu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishesh","family":"Gumdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Koppaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema Sireesha","family":"Natti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragna Sagar","family":"Rapole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Touseef Ahmed Hussein","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"issue":"(1):","key":"key20260313051250_B1","doi-asserted-by":"crossref","first-page":"51\u2013","DOI":"10.1002\/cncr.20312","article-title":"Breast carcinoma in men: a population-based study.","volume":"101","author":"Giordano","year":"2004;","journal-title":"Cancer"},{"issue":"(1):","key":"key20260313051250_B2","doi-asserted-by":"crossref","first-page":"34\u2013","DOI":"10.1007\/s11912-023-01489-z","article-title":"Male breast cancer: a review on diagnosis, treatment, and survivorship.","volume":"26","author":"Bhardwaj","year":"2024;","journal-title":"Curr Oncol Rep"},{"issue":"(9):","key":"key20260313051250_B3","doi-asserted-by":"crossref","first-page":"1034\u2013","DOI":"10.1093\/bjs\/znab279","article-title":"Treatment of male breast cancer: meta-analysis of real-world evidence.","volume":"108","author":"Lin","year":"2021;","journal-title":"Br J Surg"},{"issue":"(6):","key":"key20260313051250_B4","doi-asserted-by":"crossref","first-page":"1434\u2013","DOI":"10.1093\/annonc\/mdt025","article-title":"Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship.","volume":"24","author":"Ruddy","year":"2013;","journal-title":"Ann Oncol"},{"issue":"(3):","key":"key20260313051250_B5","doi-asserted-by":"crossref","first-page":"246\u2013","DOI":"10.1016\/j.critrevonc.2009.04.002","article-title":"Male breast cancer: evolution of treatment and prognostic factors. Analysis of 489 cases.","volume":"73","author":"Cutuli","year":"2010;","journal-title":"Crit Rev Oncol Hematol"},{"issue":"(6):","key":"key20260313051250_B6","doi-asserted-by":"crossref","first-page":"1208\u2013","DOI":"10.1158\/1078-0432.CCR-19-2580","article-title":"FDA approval summary: palbociclib for male patients with HR-positive, HER2-negative breast cancer.","volume":"26","author":"Wedam","year":"2020;","journal-title":"Clin Cancer Res"},{"issue":"(5):","key":"key20260313051250_B7","doi-asserted-by":"crossref","first-page":"489\u2013","DOI":"10.1016\/j.breast.2014.08.009","article-title":"ESO\u2013ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).","volume":"23","author":"Cardoso","year":"2014;","journal-title":"Breast"},{"issue":"(8):","key":"key20260313051250_B8","doi-asserted-by":"crossref","first-page":"1918\u2013","DOI":"10.1002\/ijc.27841","article-title":"An international comparison of male and female breast cancer incidence rates.","volume":"132","author":"Ly","year":"2013;","journal-title":"Int J Cancer"},{"issue":"(2):","key":"key20260313051250_B9","doi-asserted-by":"crossref","first-page":"122\u2013","DOI":"10.1056\/NEJMoa1703643","article-title":"Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer.","volume":"377","author":"von Minckwitz","year":"2017;","journal-title":"N Engl J Med"},{"issue":"(11):","key":"key20260313051250_B10","doi-asserted-by":"crossref","first-page":"103938.","DOI":"10.1016\/j.esmoop.2024.103938","article-title":"Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer (BIG 2-06\/NCCTG N063D [Alliance]).","volume":"9","author":"de Azambuja","year":"2024;","journal-title":"ESMO Open"},{"issue":"(12):","key":"key20260313051250_B11","doi-asserted-by":"crossref","first-page":"2114\u2013","DOI":"10.1200\/JCO.2009.25.5729","article-title":"Multidisciplinary meeting on male breast cancer: summary and research recommendations.","volume":"28","author":"Korde","year":"2010;","journal-title":"J Clin Oncol"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:12:59Z","timestamp":1773378779000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-3-56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.59556\/japi.74.1427"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1427","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}